Joint Pain Injection Market Scope And Analysis

Joint Pain Injection Market Report Scope

 

Distribution Channel-based Insights

Based on distribution channel, the joint pain injection market is segmented into retail pharmacies, hospitals pharmacies, and others. The wound care segment held the largest market share in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the joint pain injection market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.

Joint Pain Injection Market – by Drug

• Hyaluronic Acid
• Corticosteroid
• Others

Joint Pain Injection Market – by Joint Type

• Knee
• Foot and Ankle
• Shoulder and Elbow
• Hip
• Others

Joint Pain Injection Market – by Distribution Channel

• Retail Pharmacies
• Hospitals Pharmacies
• Others

Joint Pain Injection Market – by Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

• Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa

• South and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

• Chugai Pharmaceutical Co., Ltd.            
• Bioventus Inc.       
• Fidia Pharma USA Inc.      
• Flexion Therapeutics, Inc.           
• SEIKAGAKU CORPORATION         
• Ferring B.V.           
• Sanofi         
• Anika Therapeutics, Inc.             
• Teva Pharmaceutical        
• OrthogenRx, Inc.